Home › Funds › ARS Wealth Advisors Group, LLC › GSK
ARS Wealth Advisors Group, LLC position in GSK
GSK PLC ADR F · Health Care
ARS Wealth Advisors Group, LLC reported holding 129,116 shares of GSK (GSK PLC ADR F) in its Q3 2026 13F filing — a position valued at US$6.2M, representing 0.45% of its reported portfolio and ranking #44 among its reported holdings. ARS Wealth Advisors Group, LLC has disclosed GSK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR
How ARS Wealth Advisors Group, LLC's GSK position evolved
ARS Wealth Advisors Group, LLC first disclosed a stake in GSK in Q1 2026 at 127,516 shares (US$7.0M). Across 3 filings, ARS Wealth Advisors Group, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 129,116 shares valued at US$6.2M — an increase of 1,478 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 127.52K | $7.04M | New |
| Q2 2026 | 127.64K | $6.69M | Hold |
| Q3 2026 | 129.12K | $6.22M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on ARS Wealth Advisors Group, LLC
FAQ
How long has ARS Wealth Advisors Group, LLC held GSK?
ARS Wealth Advisors Group, LLC has disclosed GSK holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is ARS Wealth Advisors Group, LLC's current position in GSK?
As of Q3 2026, ARS Wealth Advisors Group, LLC holds 129.12K shares of GSK (GSK PLC ADR F), valued at $6.22M, representing 0.45% of its reported portfolio and ranking #44.
Has ARS Wealth Advisors Group, LLC been buying or selling GSK?
In the latest 13F filing (Q3 2026), ARS Wealth Advisors Group, LLC increased its position in GSK.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.